BACKGROUND: A chief morbidity of @entity2103 is ocular exposure, which is largely due to lower lid retraction and ectropion. OBJECTIVE: To assess the role of midfacial elevation in the comprehensive surgical treatment of @entity8442 lower lid malposition and ocular exposure. METHODS: Eleven @entity1 with chronic @entity2103 causing symptomatic ocular exposure were treated with subperiosteal midface elevation as a component of comprehensive lower lid elevation. Other procedures were performed concomitantly to treat lower lid ligament laxity and reduced lower @entity2003 , as required. Preoperative and postoperative ocular exposure symptoms, visual acuity, lower lid position, lagophthalmos, and @entity2372 were compared. RESULTS: At an average of 17 months of follow-up, all @entity1 reported improvement in symptoms. Visual acuity was maintained or improved in all @entity1 . Lower eyelid position (P =.003), lagophthalmos (P =.07), and @entity2372 (P<.001) were also improved. CONCLUSIONS: Midfacial elevation is a safe and effective surgical adjunct in the treatment of lower eyelid retraction in chronic @entity3541 . Its use reduces the need for tarsorrhaphy, which limits the binocular visual field and negatively impacts cosmesis.

Comprehensive midfacial elevation for ocular complications of XXXX .

@entity1 :: ('9606', 'Species') :: ['patients'] @entity2003 :: ('MESH:D009127', 'Disease') :: ['lid rigidity'] @entity2372 :: ('MESH:C562399', 'Disease') :: ['keratopathy'] @entity8442 :: ('MESH:D007418', 'Disease') :: ['paralytic'] @entity2103 :: ('MESH:D005155', 'Disease') :: ['facial nerve palsy'] @entity3541 :: ('MESH:D005158', 'Disease') :: ['facial palsy']
@entity2103 :: (MESH:D005155,Disease) :: ['facial nerve palsy']
